Download PDF
Zeitschrift für Komplementärmedizin 2017; 09(05): 28-33
DOI: 10.1055/s-0043-118915
Praxis
Umweltmedizin
© Karl F. Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Integrative Behandlung von Patienten mit Parkinson

Joachim Mutter
Subject Editor:
Further Information

Publication History

Publication Date:
19 September 2017 (online)

    Permissions and Reprints

Zusammenfassung

In den meisten Fällen ist die Ursache einer Morbus-Parkinson-Erkrankung unklar. Die konventionellen Behandlungsoptionen sind nicht immer ausreichend oder werden aufgrund unerwünschter Wirkungen von den Patienten abgelehnt.

Verschiedene Studien legen den Einfluss von Umweltfaktoren auf die Entstehung neurodegenerativer Erkrankungen wie Morbus Parkinson nahe. Insbesondere Schwermetallbelastungen durch Zahnmaterialien scheinen eine Rolle zu spielen.

Mit einer integrativen Therapie, die u. a. die Ernährung, den Mikronährstoffstatus, Schwermetallbelastungen und mögliche neurotrope Infektionen berücksichtigt, kann der Behandlungserfolg erheblich verbessert bzw. die Krankheitsprogression gestoppt werden.

Keywords

Morbus Parkinson - Integrative Therapie - Umweltmedizin - DMPS - Entgiftung - Mikronährstoffe - Borrelien
 

  • Literatur

  • 1 Berlin M, Zalups RK, Fowler BA. et al. In: Nordberg GF, Fowler BA, Nordberg M et al. eds Handbook on the Toxicology of Metals.. Vol. 2; 4th ed Amsterdam: Elsevier; 2015: 1013-1075
    CrossrefSearch in Google Scholar
  • 2 Bjørklund G.. Parkinson’s disease and mercury.. J Orthomol Med 1995; 10 (02) 147-148
    Search in Google Scholar
  • 3 Bjørklund G.. Parkinson disease, mercury and other heavy metals (in Norwegian).. Tidsskr Nor Laegeforen 1995; 115 (06) 757-222
    PubMedSearch in Google Scholar
  • 4 Bjørklund G. et al. Metals in Parkinson’s disease.. Current Medicinal Chemistry: 2017. (in press)
    Search in Google Scholar
  • 5 Blázquez L, Otaegui DSáenz. et al. Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson’s disease.. Neurosci Lett 2006; 406 (03) 235-239
    CrossrefPubMedSearch in Google Scholar
  • 6 Egilman DS, Bohme SR.. Over a barrel: corporate corruption of science and its effects on workers and the environment. Int J Occup Environ Health 2005; 11 (04) 331-337
    CrossrefPubMedSearch in Google Scholar
  • 7 Dantzig PI.. Parkinson’s disease, macular degeneration and cutaneous signs of mercury toxicity.. J Occup Environ Med 2006; 48 (07) 656
    PubMedSearch in Google Scholar
  • 8 David RA, Zimmermann MR.. Cancer: an old disease,. a new disease or something in between? Nature Reviews Cancer 2010; 10: 728-733
    PubMedSearch in Google Scholar
  • 9 de Lau LM, Breteler MM.. Epidemiology of Parkinson's disease.. Lancet Neurol 2006; 5 (06) 525-535
    CrossrefPubMedSearch in Google Scholar
  • 10 Farrer LA, Cupples LA, Haines JL. et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease.. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997; 278 (16) 1349-1356
    PubMedSearch in Google Scholar
  • 11 Feng J, Auwaerter PG, Zhang Y.. Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline.. PLoS One 2015; 10 (03) e0117207
    CrossrefPubMedSearch in Google Scholar
  • 12 Feng J, Weitner M, Shi W. et al. Eradication of biofilm-like microcolony structures of Borrelia burgdorferi by daunomycin and daptomycin but not mitomycin C in combination with doxycycline and cefuroxime.. Front Microbiol 2016; 07: 62
    Search in Google Scholar
  • 13 Feng J, Shi W, Zhang S. et al. A drug combination screen identifies drugs active against amoxicillin-induced round bodies of in vitro Borrelia burgdorferi persisters from an FDA drug library.. Front Microbiol 2016; 7-743
    PubMedSearch in Google Scholar
  • 14 Feng J, Zhang S, Shi W. et al. Ceftriaxone pulse dosing fails to eradicate biofilm-like microcolony B. burgdorferi persisters which are sterilized by daptomycin/doxycycline/cefuroxime without pulse dosing.. Front Microbiol 2016; 7-1744
    PubMedSearch in Google Scholar
  • 15 Godfrey ME, Wojcik DP, Krone CA. Apolipoprotein E genotyping as a potential biomarker for mercury neurotoxicity.. J Alzheimers Dis 2003; 5 (03) 189-195
    CrossrefPubMedSearch in Google Scholar
  • 16 Goldman SM, Tanner CM, Olanow CW. et al. Occupation and parkinsonism in three movement disorders clinics.. Neurology 2005; 65 (09) 1430-1435
    CrossrefPubMedSearch in Google Scholar
  • 17 Gratwicke J, Jahanshahi M, Foltynie T. Parkinson's disease dementia: a neural networks perspective.. Brain 2015; 138: 1454-1476 (Pt 6)
    CrossrefPubMedSearch in Google Scholar
  • 18 Haley BE. Mercury toxicity: Genetic susceptibility and synergistic effects.. Med Veritas 2005; 535-542
    Search in Google Scholar
  • 19 Hsu YC, Chang CW, Lee HL. et al. Association between history of dental amalgam fillings and risk of parkinson’s disease: A population-based retrospective cohort study in Taiwan.. PloS one 2016; 11 (12) e0166552.
    CrossrefPubMedSearch in Google Scholar
  • 20 Lechner J, von Baehr V. RANTES and fibroblast growth factor 2 in jawbone cavitations:. triggers for systemic disease? Int J Gen Med 2013; 6: 277-290
    PubMedSearch in Google Scholar
  • 21 Leong CC, Syed NI, Lorscheider FL. Retrograde degeneration of neurite membrane structural integrity of nerve growth cones following in vitro exposure to mercury.. Neuroreport 2001; 12 (04) 733-737
    CrossrefPubMedSearch in Google Scholar
  • 22 Lichtenstein P, Holm NV, Verkasalo PK. et al. Environmental and heritable factors in the causation of cancer – analyses of cohorts of twins from Sweden, Denmark, and Finland.. N Engl J Med 2000; 343: 78-85
    CrossrefPubMedSearch in Google Scholar
  • 23 López M, Guerrero J, Yescas P. et al. Apolipoprotein E epsilon4 allele is associated with Parkinson disease risk in a Mexican Mestizo population.. Mov Disord 2007; 22 (03) 417-420
    CrossrefPubMedSearch in Google Scholar
  • 24 Mangelsdorf I, Walach H, Mutter J.. Healing of Amyotrophic Lateral Sclerosis: a case report.. Complement Med Res 2017; 24 (03) 175-181
    CrossrefPubMedSearch in Google Scholar
  • 25 Mutter J. Entgiftung: Effektiv bei vielen Krankheiten.. OM 2016; 4: 5-15
    Search in Google Scholar
  • 26 Mutter J.. Lass Dich nicht vergiften. 5 Aufl.. GU: München; 2016
    Search in Google Scholar
  • 27 Mutter J.. Is dental amalgam safe for humans? The opinion of the scientific committee of the European Commission.. J Occup Med Toxicol 2011; 6 (02) 1-17
    CrossrefPubMedSearch in Google Scholar
  • 28 Mutter J. Gesund statt chronisch krank. 3. Aufl.. Weil der Stadt; Naturaviva: 2012
    Search in Google Scholar
  • 29 Ngim CH, Devathasan G.. Epidemiologic study on the association between body burden mercury level and idiopathic Parkinson's disease.. Neuroepidemiology 1989; 8 (03) 128-141
    CrossrefPubMedSearch in Google Scholar
  • 30 Olivieri G, Brack C. Müller-Spahn F et al. Mercury induces cell cytotoxicity and oxidative stress and increases beta-amyloid secretion and tau phosphorylation in SHSY5Y neuroblastoma cells.. J Neurochem 2000; 74 (01) 231-236
    CrossrefPubMedSearch in Google Scholar
  • 31 Olivieri G, Novakovic M, Savaskan E. et al. The effects of beta-estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and beta-amyloid secretion.. Neuroscience 2002; 113 (04) 849-855
    CrossrefPubMedSearch in Google Scholar
  • 32 Papp A, Pecze L, Szabó A. et al. Effects on the central and peripheral nervous activity in rats elicited by acute administration of lead, mercury and manganese, and their combinations.. J Appl Toxicol 2006; 26 (04) 374-380
    CrossrefPubMedSearch in Google Scholar
  • 33 Schubert J, Riley EJ, Tyler SA. Combined effects in toxicology – a rapid systematic testing procedure: cadmium, mercury, and lead.. J Toxicol Environ Health 1978; 4 (05) (06) 763-776
    CrossrefPubMedSearch in Google Scholar
  • 34 Schulte PA, Burnett CA. Boeniger MF et al. Neurodegenerative diseases: occupational occurrence and potential risk factors, 1982 through 1991.. Am J Public Health 1996; 86 (09) 1281-1288
    CrossrefPubMedSearch in Google Scholar
  • 35 Seidler A, Hellenbrand W, Robra BP. et al. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany.. Neurology 1996; 46 (05) 1275-1284
    CrossrefPubMedSearch in Google Scholar
  • 36 Stewart WF, Schwartz BS, Simon D. et al. ApoE genotype, past adult lead exposure, and neurobehavioral function.. Environ Health Perspect 2002; 110 (05) 501-505
    CrossrefPubMedSearch in Google Scholar
  • 37 Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer's disease.. Annu Rev Neurosci 1996; 19: 53-77
    CrossrefPubMedSearch in Google Scholar
  • 38 Sun H. Association of soil selenium, strontium, and magnesium concentrations with Parkinson’s disease mortality rates in the USA.. Environ Geochem Health 2017; 7: 1-9
    Search in Google Scholar
  • 39 Tanner CM, Kamel F, Ross GW. et al. Rotenone, paraquat, and Parkinson's disease.. Environ Health Perspect 2011; 119 (06) 866-872
    CrossrefPubMedSearch in Google Scholar
  • 40 Tanner CM, Ottman R, Goldman SM. et al. Parkinson disease in twins: an etiologic study.. JAMA 1999; 281 (04) 341-346
    CrossrefPubMedSearch in Google Scholar
  • 41 WHO – World Health Organization. Inorganic mercury. Environmental Health Criteria, 118. Geneva: World Health Organization 1991
    PubMed